|
[1]
|
UNAIDS. Global AIDS update 2024,https://www.unaids.org, [2024]. |
|
[2]
|
Fauci AS. An HIV vaccine is essential for ending the HIV/AIDS pandemic. JAMA 2017;318(16):1535 − 6. https://doi.org/10.1001/jama.2017.13505CrossRef
|
|
[3]
|
Gregson J, Tang M, Ndembi N, Hamers RL, Rhee SY, Marconi VC, et al. Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study. Lancet Infect Dis 2016;16(5):565 − 75. https://doi.org/10.1016/S1473-3099(15)00536-8CrossRef
|
|
[4]
|
Gaschen B, Taylor J, Yusim K, Foley B, Gao F, Lang D, et al. Diversity considerations in HIV-1 vaccine selection. Science 2002;296(5577):2354 − 60. https://doi.org/10.1126/science.1070441CrossRef
|
|
[5]
|
Hemelaar J, Elangovan R, Yun J, Dickson-Tetteh L, Fleminger I, Kirtley S, et al. Global and regional molecular epidemiology of HIV-1, 1990-2015: a systematic review, global survey, and trend analysis. Lancet Infect Dis 2019;19(2):143 − 55. https://doi.org/10.1016/S1473-3099(18)30647-9CrossRef
|
|
[6]
|
Williams A, Menon S, Crowe M, Agarwal N, Biccler J, Bbosa N, et al. Geographic and population distributions of human immunodeficiency virus (HIV)–1 and HIV-2 circulating subtypes: a systematic literature review and meta-analysis (2010–2021). J Infect Dis 2023;228(11):1583 − 91. https://doi.org/10.1093/infdis/jiad327CrossRef
|
|
[7]
|
Hao JJ, Zheng S, Gan MZ, Dong AB, Kang RH, Li MM, et al. Changing proportions of HIV-1 subtypes and transmitted drug resistance among newly diagnosed HIV/AIDS individuals - China, 2015 and 2018. China CDC Wkly 2021;3(53):1133 − 8. https://doi.org/10.46234/ccdcw2021.251CrossRef
|
|
[8]
|
Li Z, He X, Wang Z, Xing H, Li F, Yang Y, et al. Tracing the origin and history of HIV-1 subtype B′ epidemic by near full-length genome analyses. AIDS 2012;26(7):877 − 84. https://doi.org/10.1097/QAD.0b013e328351430dCrossRef
|
|
[9]
|
Li L, Sun GQ, Zhong P, Han JW, Li TY, Jia DJ, et al. HIV‐1 Thai B strain has spread out of former plasma donors into general population through sexual contact in Henan, China. J Med Virol 2016;88(4):614 − 21. https://doi.org/10.1002/jmv.24383CrossRef
|
|
[10]
|
Feng Y, He X, Hsi JH, Li F, Li XG, Wang Q, et al. The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s. AIDS 2013;27(11):1793 − 802. https://doi.org/10.1097/QAD.0b013e328360db2dCrossRef
|
|
[11]
|
Wang XL, He X, Zhong P, Liu YJ, Gui T, Jia DJ, et al. Phylodynamics of major CRF01_AE epidemic clusters circulating in mainland of China. Sci Rep 2017;7(1):6330. https://doi.org/10.1038/s41598-017-06573-6CrossRef
|
|
[12]
|
Gan MZ, Zheng S, Hao JJ, Ruan YH, Liao LJ, Shao YM, et al. Spatiotemporal patterns of CRF07_BC in China: a population-based study of the HIV strain with the highest infection rates. Front Immunol 2022;13:824178. https://doi.org/10.3389/fimmu.2022.824178CrossRef
|
|
[13]
|
Feng Y, Takebe Y, Wei HM, He X, Hsi JH, Li ZP, et al. Geographic origin and evolutionary history of China’s two predominant HIV-1 circulating recombinant forms, CRF07_BC and CRF08_BC. Sci Rep 2016;6:19279. https://doi.org/10.1038/srep19279CrossRef
|
|
[14]
|
Gan MZ, Zheng S, Hao JJ, Ruan YH, Liao LJ, Shao YM, et al. The prevalence of CRF55_01B among HIV-1 strain and its connection with traffic development in China. Emerg Microbes Infect 2021;10(1):256 − 65. https://doi.org/10.1080/22221751.2021.1884004CrossRef
|
|
[15]
|
Li K, Chen HH, Li JJ, Feng Y, Liang SJ, Rashid A, et al. Distinct genetic clusters in HIV-1 CRF01_AE-infected patients induced variable degrees of CD4+ T-cell loss. mBio 2024;15(3):e0334923. https://doi.org/10.1128/mbio.03349-23CrossRef
|
|
[16]
|
Ma LY, Guo YF, Yuan L, Huang Y, Sun JP, Qu SL, et al. Phenotypic and genotypic characterization of human immunodeficiency virus type 1 CRF07_BC strains circulating in the Xinjiang province of China. Retrovirology 2009;6:45. https://doi.org/10.1186/1742-4690-6-45CrossRef
|
|
[17]
|
Liu YJ, Li HP, Wang XL, Han JW, Jia L, Li TY, et al. Natural presence of V179E and rising prevalence of E138G in HIV-1 reverse transcriptase in CRF55_01B viruses. Infect Genet Evol 2020;77:104098. https://doi.org/10.1016/j.meegid.2019.104098CrossRef
|
|
[18]
|
Wei L, Li H, Lv X, Zheng CL, Li GL, Yang ZR, et al. Impact of HIV-1 CRF55_01B infection on the evolution of CD4 count and plasma HIV RNA load in men who have sex with men prior to antiretroviral therapy. Retrovirology 2021;18(1):22. https://doi.org/10.1186/s12977-021-00567-zCrossRef
|